Zhu Huang
Research Subjects
Research Interests
Zhu Huang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Fang Xu
Department of Ophthalmology, Jiaozhou Central Hospital of Qingdao, Qingdao, Shandong, China
1 shared publication - Tao Zhao
Department of Central Laboratory, Shandong Provincial Key Medical and Health Laboratory of The People’s Hospital of Rizhao, Rizhao Key Laboratory of Basic Research on Anesthesia and Respiratory Intensive Care, The People’s Hospital of Rizhao, Rizhao, China
1 shared publication - Wenwen Hao
Department of Ophthalmology, Jiaozhou Central Hospital of Qingdao, Qingdao, Shandong, China
1 shared publication - Xin’AI Zhang
Department of Ophthalmology, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China
1 shared publication
Latest Publications
- Open Access
- 30 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (5) , e47370
Ferroptosis in glaucoma: Identification of key genes NR1D2 and AKR1C3 based on transcriptome bioinformatics analysis
Glaucoma, a leading cause of blindness, involves retinal ganglion cell death linked to ferroptosis, an iron-dependent form of cell death. This study analyzed GEO datasets (GSE9944 and GSE2378) to identify ferroptosis-related genes in glaucoma. Least absolute shrinkage and selection operator and support vector machine-recursive feature elimination methods were used to select key genes, and bioinformatics tools were applied to assess their diagnostic potential and biological significance. NR1D2 and AKR1C3 were identified as key ferroptosis-related genes with high diagnostic potential. These genes are involved in redox reactions, cellular processes, and immune responses. Drug sensitivity and competitive endogenous RNA network analyses further confirmed their value as potential diagnostic biomarkers and therapeutic targets. NR1D2 and AKR1C3 are promising biomarkers for diagnosing glaucoma and serve as potential therapeutic targets, offering new insights into its pathogenesis and treatment strategies.
- 30 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (5) , e47370
Open AccessFerroptosis in glaucoma: Identification of key genes NR1D2 and AKR1C3 based on transcriptome bioinformatics analysis
Glaucoma, a leading cause of blindness, involves retinal ganglion cell death linked to ferroptosis, an iron-dependent form of cell death. This study analyzed GEO datasets (GSE9944 and GSE2378) to identify ferroptosis-related genes in glaucoma. Least absolute shrinkage and selection operator and support vector machine-recursive feature elimination methods were used to select key genes, and bioinformatics tools were applied to assess their diagnostic potential and biological significance. NR1D2 and AKR1C3 were identified as key ferroptosis-related genes with high diagnostic potential. These genes are involved in redox reactions, cellular processes, and immune responses. Drug sensitivity and competitive endogenous RNA network analyses further confirmed their value as potential diagnostic biomarkers and therapeutic targets. NR1D2 and AKR1C3 are promising biomarkers for diagnosing glaucoma and serve as potential therapeutic targets, offering new insights into its pathogenesis and treatment strategies.